Van Eck Associates Corp Crispr Therapeutics Ag Transaction History

Van Eck Associates Corp

$80.1 Billion
Q3 2024

A detailed history of Van Eck Associates Corp transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Van Eck Associates Corp holds 1,546 shares of CRSP stock, worth $80,206. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,546

Previous 79,774 98.06%

Holding current value

$80,206

Previous $4.31 Million 98.35%

% of portfolio

0.0%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$44.62 - $62.75 $3.49 Million - $4.91 Million	-78,228 Reduced 98.06%	1,546 $71,000
Q2 2024 Jul 31, 2024	BUY	$51.17 - $68.18 $400,661 - $533,849	7,830 Added 10.88%	79,774 $4.31 Million
Q1 2024 Apr 30, 2024	BUY	$60.67 - $89.12 $248,929 - $365,659	4,103 Added 6.05%	71,944 $4.9 Million
Q4 2023 Feb 05, 2024	SELL	$38.62 - $72.18 $192,675 - $360,106	-4,989 Reduced 6.85%	67,841 $4.25 Million
Q3 2023 Nov 08, 2023	SELL	$45.39 - $59.0 $178,518 - $232,047	-3,933 Reduced 5.12%	72,830 $3.31 Million
Q2 2023 Aug 03, 2023	SELL	$43.47 - $67.77 $254,864 - $397,335	-5,863 Reduced 7.1%	76,763 $4.31 Million
Q1 2023 May 03, 2023	SELL	$41.0 - $56.12 $439,315 - $601,325	-10,715 Reduced 11.48%	82,626 $3.74 Million
Q4 2022 Feb 08, 2023	BUY	$39.19 - $65.67 $551,951 - $924,896	14,084 Added 17.77%	93,341 $3.79 Million
Q3 2022 Oct 27, 2022	SELL	$61.1 - $83.78 $2.87 Million - $3.94 Million	-47,002 Reduced 37.23%	79,257 $5.18 Million
Q2 2022 Aug 03, 2022	BUY	$43.23 - $73.83 $527,319 - $900,578	12,198 Added 10.69%	126,259 $7.67 Million
Q1 2022 May 10, 2022	BUY	$53.19 - $79.24 $532,697 - $793,588	10,015 Added 9.63%	114,061 $7.16 Million
Q4 2021 Jan 26, 2022	BUY	$70.09 - $111.29 $539,272 - $856,265	7,694 Added 7.99%	104,046 $7.88 Million
Q3 2021 Nov 03, 2021	SELL	$110.2 - $156.64 $860,331 - $1.22 Million	-7,807 Reduced 7.5%	96,352 $10.8 Million
Q2 2021 Aug 10, 2021	SELL	$100.84 - $161.89 $1.5 Million - $2.42 Million	-14,922 Reduced 12.53%	104,159 $16.9 Million
Q1 2021 May 13, 2021	BUY	$110.72 - $210.04 $13.2 Million - $25 Million	119,081 New	119,081 $14.5 Million

Others Institutions Holding CRSP

# of Institutions

499

Shares Held

56.8M

Call Options Held

1.7M

Put Options Held

1.8M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.05B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Account

Van Eck Associates Corp Crispr Therapeutics Ag Transaction History